Webinar: Industry Insights: Navigating Challenges in Immune Cell Therapy Analysis

As scientific and technological breakthroughs continue to revolutionize the landscape of immune cell therapy, the rapid industry growth has brought about significant challenges and bottlenecks to developers and manufacturers, such as scalability, regulatory hurdles, and data standardization. In this insightful conversation, our panel of industry experts navigate these issues, alongside emerging trends and novel analytical approaches within immune cell therapy development and evaluation.

Discussion Topics:

• The impact of automation for immune cell therapy manufacturers
• Rethinking traditional methods and minimizing bias and errors in analytical assays
• The challenges of going beyond blood cancers in immune cell therapy
• Gene editing of immune cells: viral vs. non-viral methods
• The rise of closed-system cell manufacturing platforms

Panelists

Juan F. Vera, President & CEO, Marker Therapeutics

Andrew Greenwald, Scientist, Genezen Laboratories

Mitchell Ambrosino, Senior Associate Scientist, Be Biopharma

David Hermanson, Director, Cell & Gene Therapy Applications, Bio-Techne

Moderator

Nathan Allen, Director, Product Marketing Management, Cell & Gene Therapy, Bio-Techne

This presentation was recorded as part of the Virtual Immune Cell Therapy Symposium on September 27, 2023.